JPRN-jRCT2080224657已完成1 期
A Phase I/II, pharmacokinetics and dose-finding study of M121101 in patients with pincer nail
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Pincer nail patients
排除标准
- •(1)Subjects with complications of any of ingrown nail, onychomycosis, nail psoriasis, onychogryphosis, and pachyonychia at the application site
- •(2)Subjects with the clinically significant liver, kidney, heart, or lung diseases that require hospitalization
研究者
相似试验
招募中
1 期
Phase I study of optimal dose and pharmacokinetics of a Uracil/Tegafur (UFT) plus oral leucovorin regimen after liver resection for colorectal liver metastasisiver resection for liver metastasis of colorectal cancerJPRN-UMIN000021146Oita university, faculty of medicine, department gastroenterology and pediatric surgery18
已完成
2 期
Pharmacokinetic, pharmacodynamic and phase II study of gefitinib in patients with malignant pleural effusion from non-small cell lung canceron-small cell lung cancerJPRN-UMIN000002953ational Hospital Organization Kinki-Chuo Chest Medical Center20
进行中（未招募）
1 期
Phase II, randomized, pharmokinetic, dose finding, and dose frequency determination using rt-PA in intraventricular hemorrhage - CLEAR IVHIntracerebral haemorrhage with intraventricular extensionEUCTR2004-000919-26-GBewcastle upon Tyne Hospitals NHS Trust52
进行中（未招募）
1 期
Phase II, randomized, pharmokinetic, dose finding, and dose frequency determination using rt-PA in intraventricular hemorrhage - CLEAR IVHEUCTR2004-000919-26-FIewcastle upon Tyne Hospitals NHS Trust52
已完成
1 期
A clinical study to evaluate the Pharmacokinetic and Pharmacodynamic properties of Darbepoetin alfa Injection, Hetero and â??ARANESP®â?? (Darbepoetin alfa Injection, Amgen), in Healthy Adult Human SubjectsCTRI/2016/03/006727Hetero Drugs Limited52